<DOC>
	<DOCNO>NCT02547441</DOCNO>
	<brief_summary>This study evaluate safety efficacy once-daily application CLS001 topical gel compare vehicle gel subject severe papulopustular rosacea .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy Once-Daily CLS001 Topical Gel Versus Vehicle</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>1 . Healthy , male nonpregnant female subject , 18 year age old . 2 . A diagnosis papulopustular rosacea â‰¥30 inflammatory facial lesion Baseline . Subjects must 2 nodular lesion , Baseline . 3 . Subjects presence telangiectasia Baseline . 4 . Subjects erythema score least 2 Investigator Assessment Erythema scale Baseline . 5 . Subjects severe rosacea Investigators Global Assessment scale Baseline . 1 . Subjects steroid rosacea subtype 3 ( phymatous rosacea ) . 2 . Subjects nodular rosacea . 3 . Standard exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>